medigraphic.com
ISSN 1561-3062 (Electronic)

2022, Number 4

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2022; 48 (4)

Evolution of adiponectin levels and their relationship with lipid profile and insulin levels

Osorio JH, Quenan CYE

Language: Spanish
References: 26
Page:
PDF size: 364.08 Kb.


ABSTRACT

Introduction: Adipose tissue during pregnancy increases its metabolic activity, producing adipocytokines, which exert endocrine and paracrine activities, therefore, weight gain is normal, however, its deregulation generates diabetes mellitus and preeclampsia among others.
Objective: To determine the evolution of adiponectin levels during normal pregnancy and its relationship with the lipid profile and insulin.
Methods: Fasting blood samples were taken from 73 pregnant women with normal pregnancies, average age of 22 years, during the first, second and third trimester, treated at San Marcos hospital in Chinchiná, Colombia, from November 2017 to June 2018. Adiponectin levels, lipid profile and insulin in blood were determined.
Results: A statistically significant difference was obtained in adiponectin values between the first, second and third trimester of pregnancy. In the lipid profile, a statistically significant difference was found among the different trimesters in the values of triglycerides, total cholesterol and low-density lipoprotein cholesterol. Insulin values were found to be high in all trimesters.
Conclusions: During normal pregnancy, adiponectin values are decreased, with decreasing trend towards the second and third trimester. No correlation was observed among the behavior of adiponectin levels during pregnancy and the other metabolites analyzed.


REFERENCES

  1. Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr. 2000;54(Suppl 1):47-51. DOI: https://doi.org/10.1038/sj.ejcn.1600984

  2. Kapoor N, Sankaran S. Diabetes in pregnancy: a review of current evidence. Curr Opin Obstet Gynecol. 2007;19:586-90. DOI: https://doi.org/10.1097/GCO.0b013e3282f20

  3. Mission JF, Marshall NE, Caughey AB. Obesity in pregnancy: a big problem and getting bigger. Obstet Gynecol Surv. 2013;68:389-99. DOI: https://doi.org/10.1097/OGX.0b013e31828738ce

  4. Osorio JH. Metabolismo de los lípidos durante el embarazo. Rev Colomb Obstet Ginecol. 2000;51:113-7. DOI: https://doi.org/10.18597/rcog.692

  5. Landázuri P, Restrepo B, Trejos J, Gallego ML, Loango Chamorro N, Ocampo R. Perfil lipídico por trimestres de gestación en una población de mujeres colombianas. Rev. Colomb. Obstet. Ginecol. 2006 [acceso 09/03/2021];57(4):256-63. Disponible en: https://revista.fecolsog.org/index.php/rcog/article/view/462

  6. Flegal KM, Margaret D, Carroll MSPH, Brian K, Kit MD, Ogden CL. (JAMA 2012;307:491-7. J Vasc Nurs. 2013;31(3):131-2. DOI: https://doi.org/10.1016/j.jvn.2013.06.004

  7. Rodríguez M, Tovar A, Del Prado M, Torres N. Mecanismos moleculares de acción de los ácidos grasos poliinsaturados y sus beneficios en la salud. Rev Invest Clin. 2005 [acceso 12/09/2021];57(3):457-72. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762005000300010&lng=es

  8. Garaulet M, Hernandez-Morante JJ, de Heredia FP, Tebar FJ. Adiponectin, the controversial hormone. Public Health Nutr. 2007;10:1145-50. DOI: https://doi.org/10.1017/S1368980007000638

  9. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab. 2007;9(3):282-9. DOI: https://doi.org/10.1111/j.1463-1326.2006.00610.x

  10. Quenan YE, Osorio JH. Relación entre obesidad, adipocitoquinas y osteoatrosis: Una revisión. Univ. Salud. 2017;19(3):410-8. DOI: https://doi.org/10.22267/rus.171903.103

  11. Hernández-Valencia M, Zárate A, Galván RE. Concentración de la adiponectina en perimenopáusicas. Ginecol Obstet Mex. 2008 [acceso 06/03/2021];76(8):450-3. Disponible en https://www.imbiomed.com.mx/articulo.php?id=57909

  12. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand. 2004;83(4):341-7. DOI: https://doi.org/10.1111/j.0001-6349.2004.00413.x

  13. D'Ippolito S, Tersigni C, Scambia G, Di Simone N. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. Biofactors. 2012;38(1):14-23. DOI: https://doi.org/10.1002/biof.201

  14. Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M, et al. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia. 2005;48(5):993-1001. DOI: https://doi.org/10.1007/s00125-005-1710-x

  15. Reyna-Villasmil E, Mejia-Montilla J, Reyna-Villasmil N, Santos-Bolívar J, Torres-Cepeda D, Peña-Paredes E. Adiponectina sérica y presión arterial en preeclámpticas y eclámpticas. Clin Invest Ginecol Obstet. 2009;36:13-8. DOI: https://doi.org/10.1016/j.gine.2008.09.002

  16. Catalano PM, Thomas AJ, Huston LP, Fung CM. Effect of maternal metabolism on fetal growth and body composition. Diabetes Care. 1998 [acceso 15/07/2021];21(2):85‐90. Disponible en: https://pubmed.ncbi.nlm.nih.gov/9704233/

  17. Madhu SV, Bhardwaj S, Jhamb R, Srivastava H, Sharma S, Raizada N. Prediction of Gestational Diabetes from First Trimester Serum Adiponectin Levels in Indian Women. Indian J Endocrinol Metab. 2019;23(5):536‐9. DOI: https://doi.org/10.4103/ijem.IJEM_319_19

  18. Khosrowbeygi A, Ahmadvand H. Maternal serum levels of adiponectin in preeclampsia. J Ayub Med Coll Abbottabad. 2009 [acceso 01/04/2021];21(3):79‐82. Disponible en https://pubmed.ncbi.nlm.nih.gov/20929020/

  19. Mastorakos G, Valsamakis G, Papatheodorou DC, Barlas I, Margeli A, Boutsiadis A, et al. The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem. 2007;53:1477-83. DOI: https://doi.org/10.1373/clinchem.2006.084731

  20. Fuglsang J, Skjaerbaek C, Frystyk J, Flyvbjerg A, Ovesen P. A longitudinal study of serum adiponectin during normal pregnancy. Br J Obstet Gynaecol. 2006;113:110-3. DOI: https://doi.org/10.1111/j.1471-0528.2005.00792.x

  21. Asai-Sato M, Okamoto M, Endo M, Yoshida H, Murase M, Ikeda M, et al. Hypoadiponectinemia in lean lactating women: prolactin inhibits adiponectin secretion from human adipocytes. Endocr J. 2006;53:555-62. DOI: https://doi.org/10.1507/endocrj.k06-026

  22. Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Vaisbuch E, Gotsch F, et al. Multímeros de adiponectina en plasma materno. J Matern Fetal Neonatal Med. 2008;21(11):796-815. DOI: https://doi.org/10.1080/14767050802266881

  23. Pusukuru R, Shenoi AS, Kyada PK, Ghodke B, Mehta V, Bhuta K, et al. Evaluation of Lipid Profile in Second and Third Trimester of Pregnancy. J Clin Diagn Res. 2016;10(3):12-6. DOI: https://doi.org/10.7860/JCDR/2016/17598.7436

  24. Ywaskewycz-Benítez LR, Bonneau GA, Castillo-Rascón MS, López DL, Pedrozo WR. Perfil lipídico por trimestre de gestación en una población de mujeres adultas. Rev Chil Obstet Ginecol. 2010;75(4):227-33. DOI: http://dx.doi.org/10.4067/S0717-75262010000400003

  25. Chiefari E, Arcidiacono B, Foti D, Brunetti A. Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017;40(9):899‐909. DOI: https://doi.org/10.1007/s40618-016-0607-5

  26. Hajagos-Tóth J, Ducza E, Samavati R, Vari SG, Gaspar R. Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility. Croat Med J. 2017;58:96-104. DOI: https://doi.org/10.3325/cmj.2017.58.96




2020     |     www.medigraphic.com